Cervical Cancer News and Research

RSS

Cancer is a disease in which cells in the body grow out of control. Cancer is always named for the part of the body where it starts, even if it spreads to other body parts later. When cancer starts in the cervix, it is called cervical cancer. The cervix is the lower, narrow end of the uterus. Also known as the womb, the uterus is where a baby grows when a woman is pregnant. The cervix connects the upper part of the uterus to the vagina (birth canal).

Cervical cancer is highly preventable in most Western countries because screening tests and a vaccine to prevent HPV infections are available. When cervical cancer is found early, it is highly treatable and associated with long survival and good quality of life.

Lactate and lactylation drive metabolic, epigenetic reprogramming in gynecological cancers

Lactate, once considered a metabolic waste product, is now recognized as a key regulator of cellular homeostasis and disease progression.

31 Oct 2025

Cervical cancer patients treated with radiation and chemotherapy report greater short-term decline in quality of life

A new study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that women with early-stage cervical cancer who received radiation plus chemotherapy reported a greater short-term decline in quality of life compared to those who received radiation alone.

23 Oct 2025

Intelligent learning can accelerate global efforts to prevent cervical cancer

Cervical cancer, one of the most preventable yet lethal malignancies among women, continues to threaten lives globally due to unequal access to quality screening and diagnosis.

22 Oct 2025

Bridging innovation and equity to end cervical cancer worldwide

Each year, more than 340,000 women die from cervical cancer, with the majority of deaths occurring in low- and middle-income countries.

13 Oct 2025

AI brings hope for cervical cancer detection in rural Africa

AI can be used to detect cervical cancer in women in resource-limited parts of the world. However, for this method to work, investments are needed in healthcare staff, reliable supply chains and trust in these communities.

10 Oct 2025

PAHO concludes 62nd Directing Council with Strategic Plan 2026-2031 for healthier Americas

The 62nd Directing Council of the Pan American Health Organization (PAHO) concluded today, setting a bold agenda to address pressing health challenges across the Americas through the approval of the PAHO Strategic Plan 2026-2031 and key resolutions aimed at expanding access to high-cost high price health technologies, and preventing and controlling noncommunicable diseases (NCDs).

6 Oct 2025

PAHO introduces new tool to accelerate disease elimination in the Americas

During a briefing session at the 62nd Directing Council of the Pan American Health Organization (PAHO), officials presented a new technical tool to help countries in the Region of the Americas accelerate the elimination of more than 30 communicable diseases and related conditions.

6 Oct 2025

Health authorities approve new plan to tackle NCDs in the Americas

Health authorities from across the Americas today approved a new 2025-2030 Action Plan for the Prevention and Control of Noncommunicable Diseases (NCDs) during the 62nd Directing Council of the Pan American Health Organization (PAHO).

6 Oct 2025

New research reveals the cervix as a truly immunocompetent tissue

Cervical epithelial cells are far from passive bystanders in the body's immune system. New research shows they actually play an active and highly coordinated role in detecting and fighting infections. That's the conclusion of an international research team led by Associate Professor Cindrilla Chumduri from Aarhus University, and now published in the journal Science Advances.

6 Oct 2025

Herd immunity from HPV vaccine provides protection even for unvaccinated women

A large, long-term study led by an Albert Einstein College of Medicine researcher has found that the introduction of the human papillomavirus (HPV) vaccine in community settings is highly effective in protecting young women from infections caused by the cervical-cancer-causing virus-including women who didn't even receive the vaccine.

29 Sep 2025

Simple, affordable HPV test delivers results in less than an hour

A team of researchers led by Rice University, in collaboration with colleagues in Mozambique and The University of Texas MD Anderson Cancer Center, has developed a simple, affordable human papillomavirus (HPV) test that delivers results in less than an hour with no specialized laboratory required.

29 Sep 2025

Leading cancer organizations call for action to boost HPV vaccine coverage

VCU Massey Comprehensive Cancer Center, along with 61 other National Cancer Institute (NCI)-Designated Cancer Centers, several leading national cancer health organizations and the University of Puerto Rico Comprehensive Cancer Center, have endorsed a joint statement urging the nation's health care systems, health care providers, parents, caregivers and the public to choose the human papillomavirus (HPV) vaccination for cancer prevention.

25 Sep 2025

COST Actions drive innovation in cancer research across Europe

Cancer is a major challenge in the modern world, affecting millions of people across Europe. The prevalence of this disease requires the development of innovative and complementary treatment approaches.

19 Sep 2025

WHO's new report highlights the urgent need to address NCDs and mental health

The World Health Organization (WHO) today released a new report titled "Saving lives, spending less", revealing that an additional investment of just US$3 per person annually in tackling noncommunicable diseases (NCDs) could yield economic benefits of up to US$1 trillion by 2030.

19 Sep 2025

Study uncovers new strategy to boost life-saving cervical cancer screenings

Cervical cancer is the fourth most common cancer among women globally, according to the World Health Organization. It accounted for 660,000 new cases and 350,000 deaths in 2022.

19 Sep 2025

The 15th AACR cancer progress report highlights scientific advances

The American Association for Cancer Research (AACR) released the 15th edition of its annual Cancer Progress Report. A cornerstone of the AACR's educational and advocacy efforts, this comprehensive report provides the latest statistics on cancer incidence, mortality, and survivorship and highlights how federal investments in basic, translational, and clinical cancer research and cancer-related population sciences have led to impressive scientific advances that are improving health and saving lives.

17 Sep 2025

Survey shows ongoing misconceptions about hormone therapy safety in cancer survivors

Despite evidence suggesting the safety of hormone therapy for patients with a history of low-grade endometrial or epithelial ovarian cancer, a new survey shows that many gynecologists and some gynecologic oncologists are still uncomfortable prescribing the therapy for this patient population.

10 Sep 2025

WHO expands essential medicines lists with new cancer and diabetes treatments

Today, the World Health Organization (WHO) has released updated editions of its Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLc), adding new treatments for various types of cancer and for diabetes with associated comorbidities such as obesity.

5 Sep 2025

Yale scientists boost mRNA vaccine power with new technology

Messenger RNA, or mRNA, vaccines entered the public consciousness when they were introduced during the COVID-19 pandemic, and both Pfizer-BioNTech and Moderna used the technology in developing their highly effective vaccines to fight the virus.

27 Aug 2025

Epstein-Barr virus protein enhances cancer gene activity in HPV-positive cervical cells

A new research paper was published in Volume 16 of Genes & Cancer on August 6, 2025, titled "Epstein-Barr virus nuclear antigen 1 upregulates Derlin1 and PSMD10 expression in HeLa cells."

22 Aug 2025